Found 9 matching trials
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma PHASE2 RATIONALE: There is emerging data to suggest that the optimal use of angiog...
Show More Location
Central Georgia Hematology Oncology Associates, P.C.
Learn More & Join Trial
Atrasentan in Treating Patients With Prostate Cancer PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Jonsson Comprehensive Cancer Center, UCLA
Learn More & Join Trial
Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy PHASE2 The ASSIST study was a phase 2, double-blind, placebo-controlled crossover ...
Show More Location
University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic
Learn More & Join Trial
Atrasentan in Patients With IgA Nephropathy PHASE3 The ALIGN Study is a phase 3, double-blind, placebo-controlled study to com...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Atrasentan in Patients With Proteinuric Glomerular Diseases PHASE2 The AFFINITY Study is a phase 2, open-label, basket study to evaluate the e...
Show More Status
Active Not Recruiting
Location
Kidney Disease Medical Group
Learn More & Join Trial
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy PHASE3 RATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and a...
Show More Location
Providence Cancer Center at Providence Hospital
Learn More & Join Trial
Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of Alabama at Birmingham Comprehensive Cancer Center
Learn More & Join Trial
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN PHASE3 A Phase III, single-arm, multicenter pediatric clinical study evaluating at...
Show More Location
Hackensack Meridian Health
Learn More & Join Trial